Daniel Markowitz
Stock Analyst at Evercore ISI Group
(3.60)
# 969
Out of 5,063 analysts
18
Total ratings
56.25%
Success rate
7.67%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $190 → $250 | $230.63 | +8.40% | 2 | Nov 7, 2025 | |
| GH Guardant Health | Maintains: Outperform | $68 → $90 | $105.42 | -14.63% | 2 | Oct 30, 2025 | |
| RMBS Rambus | Maintains: Outperform | $114 → $126 | $88.15 | +42.94% | 2 | Oct 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $350 → $390 | $271.07 | +43.87% | 3 | Oct 23, 2025 | |
| TECH Bio-Techne | Maintains: Outperform | $60 → $72 | $61.53 | +17.02% | 2 | Oct 7, 2025 | |
| RGEN Repligen | Maintains: Outperform | $155 → $175 | $162.51 | +7.69% | 4 | Oct 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $89.87 | +39.09% | 2 | Oct 7, 2025 | |
| TMDX TransMedics Group | Initiates: Outperform | $155 | $130.93 | +18.38% | 1 | Sep 16, 2025 |
Natera
Nov 7, 2025
Maintains: Outperform
Price Target: $190 → $250
Current: $230.63
Upside: +8.40%
Guardant Health
Oct 30, 2025
Maintains: Outperform
Price Target: $68 → $90
Current: $105.42
Upside: -14.63%
Rambus
Oct 28, 2025
Maintains: Outperform
Price Target: $114 → $126
Current: $88.15
Upside: +42.94%
West Pharmaceutical Services
Oct 23, 2025
Maintains: Outperform
Price Target: $350 → $390
Current: $271.07
Upside: +43.87%
Bio-Techne
Oct 7, 2025
Maintains: Outperform
Price Target: $60 → $72
Current: $61.53
Upside: +17.02%
Repligen
Oct 7, 2025
Maintains: Outperform
Price Target: $155 → $175
Current: $162.51
Upside: +7.69%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $89.87
Upside: +39.09%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $130.93
Upside: +18.38%